[Research Progress on Lung Cancer Screening]

Zhongguo Fei Ai Za Zhi. 2020 Nov 20;23(11):954-960. doi: 10.3779/j.issn.1009-3419.2020.101.37. Epub 2020 Aug 21.
[Article in Chinese]

Abstract

Lung cancer is the most common malignant tumor in the world. The five-year survival rate is 19.7%, which seriously threatens human health. Lung cancer screening is an effective measure to reduce lung cancer mortality. Existing studies have shown that screening with low-dose computed tomography (LDCT) can reduce lung cancer deaths by 20%. Currently, lung cancer screening is recommended internationally and nationally. Studying the development status of lung cancer screening helps us to identify the high-risk groups of lung cancer, explore reasonable screening programs, improve the cost-effectiveness of screening and reduce the economic burden. Therefore, this article summarizes the current status of lung cancer screening, the cost-effectiveness of lung cancer screening and the existing problems as follows. .

【中文题目:肺癌筛查研究进展】 【中文摘要:肺癌是世界上最常见的恶性肿瘤,其5年生存率仅为19.7%,严重威胁人类健康。肺癌筛查是降低肺癌死亡率的有效措施,已有的研究证明用低剂量螺旋计算机断层扫描(low-dose computed tomography, LDCT)进行筛查可降低20%的肺癌死亡,目前国际和国内均建议进行肺癌筛查。研究肺癌筛查的发展现状有助于我们明确肺癌的高危人群,探索合理的筛查方案,提高筛查的成本效益,减轻经济负担。因此本文就肺癌筛查现状、肺癌筛查的成本效益以及存在的问题综述如下。 】 【中文关键词:肺肿瘤;筛查;成本效益】.

Keywords: Cost-effectiveness; Lung neoplasms; Screening.

Publication types

  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / economics
  • Mass Screening* / economics
  • Mass Screening* / methods
  • Risk Factors
  • Tomography, X-Ray Computed